# This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned.

> **NCT05946824** · PHASE2 · RECRUITING · sponsor: **University of Rochester** · enrollment: 80 (estimated)

## Conditions studied

- Recurrent Prostate Cancer After Surgery

## Interventions

- **RADIATION:** Daily-adaptive Stereotactic Body Radiation Therapy
- **RADIATION:** Daily-adaptive Stereotactic Body Radiation Therapy

## Key facts

- **NCT ID:** NCT05946824
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-14
- **Primary completion:** 2025-11-24
- **Final completion:** 2028-11-24
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05946824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05946824, "This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05946824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*